CompletedPhase 3NCT02597361

Angiotensin II Receptor Blockade in Vascular Ehlers Danlos Syndrome (ARCADE)

Studying Ehlers-Danlos syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Assistance Publique - Hôpitaux de Paris
Principal Investigator
Xavier JEUNEMAITRE, MD,PHD
AP-HP, INSERM
Intervention
Irbesartan(drug)
Enrollment
61 enrolled
Eligibility
18-70 years · All sexes
Timeline
20162020

Study locations (15)

Collaborators

Ministry of Health, France

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02597361 on ClinicalTrials.gov

Other trials for Ehlers-Danlos syndrome

Additional recruiting or active studies for the same condition.

See all trials for Ehlers-Danlos syndrome

← Back to all trials